Economic impact of keratoconus using a health expenditure questionnaire: A patient perspective.
Elsie ChanPaul N BairdSara VogrinVijaya SundararajanMark D DaniellSrujana SahebjadaPublished in: Clinical & experimental ophthalmology (2020)
Our results show that the costs associated with the diagnosis and management of keratoconus represent a significant cost to patients. An understanding of this is important not only to individuals and their families, but also health care providers, health insurers and the wider health system.